valine has been researched along with Skin Neoplasms in 22 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (9.09) | 18.2507 |
| 2000's | 5 (22.73) | 29.6817 |
| 2010's | 15 (68.18) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| De Giorgi, V; Gori, A; Massi, D; Pazzagli, M; Pinzani, P; Salvianti, F | 1 |
| Li, S; Liang, C; Nemecio, D; Quach, C; Song, Y | 1 |
| Edmonds, K; Fearfield, L; Gore, M; Larkin, J; Newton-Bishop, J; Sinha, R | 1 |
| D'Alonzo, D; Glatz, K | 1 |
| Botella, L; Callaghan, RC; Cerda-Nicolas, M; Gil-Benso, R; Gonzalez-Darder, J; Lopez-Gines, C; Muñoz-Hidalgo, L; Navarro, L; Quilis, V; San Miguel, T | 1 |
| Aktan, G; Amonkar, MM; Arance, A; Bondarenko, I; Casey, M; Chiarion-Sileni, V; de Braud, F; DeMarini, DJ; Flaherty, KT; Garbe, C; Gogas, H; Grob, JJ; Irani, JG; Larkin, J; Lebbe, C; Levchenko, E; Long, GV; Mandalà, M; Millward, M; Nathan, P; Ribas, A; Robert, C; Schadendorf, D; Stroyakovskiy, D | 1 |
| Benedict, JJ; DeConti, R; Gibney, GT; Gonzalez, RJ; Kudchadkar, RR; McCardle, T; Messina, JL; Sloot, S; Smalley, KS; Sondak, VK; Turner, LM; Weber, JS; Zager, JS | 1 |
| Anniciello, AM; Ascierto, PA; Botti, G; Favoino, E; Feldman, SA; Ferrone, CR; Ferrone, S; Flaherty, KT; Giannarelli, D; Nota, S; Palmieri, G; Pepe, S; Sabbatino, F; Scognamiglio, G; Simeone, E; Villani, V; Wang, Y | 1 |
| Mori, K; Noda, T; Ozaki, S; Sekimoto, E; Shibata, H; Shigekiyo, T; Shikiji, T; Sumitani, R; Yamashita, K | 1 |
| Al-Otaibi, LM; Al-Sulaiman, MH; Porter, SR; Teo, CG | 1 |
| Mier, JW; Panka, DJ; Sullivan, RJ | 1 |
| Coral, S; Fratta, E; Maio, M; Parisi, G; Sigalotti, L | 1 |
| Chi, Z; Cui, C; Flaherty, KT; Guo, J; Kong, Y; Li, S; Mao, L; Sheng, X; Si, L; Xu, X | 1 |
| Adekunle, V; Akolawole, M; Obiako, R; Ogoina, D; Ovosi, J; Umar, A | 1 |
| Ajouaou, A; Dankort, D; Horlings, HM; Kortman, PC; McMahon, M; Meissl, K; Michaloglou, C; Mooi, WJ; Peeper, DS; Possik, PA; Smit, MA; Vredeveld, LC | 1 |
| Clements, A; Kefford, RF; Klein, O; Long, GV; Menzies, AM; O'Toole, S | 1 |
| Niendorf, KB; Tsao, H; Yang, G | 1 |
| Barany, F; Elenitsas, R; Seykora, J; Turner, DJ; Zirvi, MA | 1 |
| Angel, C; Dobrovic, A; Dowling, JP; Kelly, JW; Liu, W; Magee, J; Mason, G; McArthur, GA; Murray, WK; Trivett, M; Wolfe, R | 1 |
| Amirkhan, RH; Frederick, GD; Friedberg, EC; Schultz, RA | 1 |
| Arden, KC; Cavenee, WK; Gutzmer, R; Herbst, RA; Kapp, A; Matiaske, F; Mommert, S; Weiss, J | 1 |
| Chidambaram, A; Fraser, MC; Goldstein, AM; Struewing, JP; Tucker, MA | 1 |
1 review(s) available for valine and Skin Neoplasms
| Article | Year |
|---|---|
Diffuse large B-cell lymphoma recurring with zosteriform cutaneous lesions.
Topics: Acyclovir; Aged; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Antiviral Agents; Cyclophosphamide; Diagnosis, Differential; Doxorubicin; Female; Herpes Zoster; Humans; Lymphoma, Large B-Cell, Diffuse; Prednisone; Recurrence; Rituximab; Skin Neoplasms; Treatment Outcome; Valacyclovir; Valine; Vincristine | 2016 |
1 trial(s) available for valine and Skin Neoplasms
| Article | Year |
|---|---|
Health-related quality of life impact in a randomised phase III study of the combination of dabrafenib and trametinib versus dabrafenib monotherapy in patients with BRAF V600 metastatic melanoma.
Topics: Amino Acid Substitution; Antineoplastic Combined Chemotherapy Protocols; Health Status; Humans; Imidazoles; Melanoma; Neoplasm Metastasis; Oximes; Pain Measurement; Proto-Oncogene Mas; Proto-Oncogene Proteins B-raf; Pyridones; Pyrimidinones; Quality of Life; Skin Neoplasms; Valine | 2015 |
20 other study(ies) available for valine and Skin Neoplasms
| Article | Year |
|---|---|
Evaluation of the liquid biopsy for the detection of BRAFV600E mutation in metastatic melanoma patients.
Topics: Amino Acid Substitution; Biomarkers, Tumor; Circulating Tumor DNA; DNA Mutational Analysis; Feasibility Studies; Glutamic Acid; Humans; Liquid Biopsy; Melanoma; Mutation; Neoplastic Cells, Circulating; Proto-Oncogene Proteins B-raf; Real-Time Polymerase Chain Reaction; Skin Neoplasms; Valine | 2019 |
Revisiting the role of autophagy in melanoma.
Topics: Amino Acid Substitution; Animals; Autophagy; Basic Helix-Loop-Helix Leucine Zipper Transcription Factors; Glutamic Acid; Humans; MAP Kinase Signaling System; Melanoma; Proto-Oncogene Proteins B-raf; Signal Transduction; Skin Neoplasms; Valine | 2019 |
Erythema nodosum-like panniculitis in patients with melanoma treated with vemurafenib.
Topics: Adult; Antineoplastic Agents; Diagnosis, Differential; Erythema Nodosum; Female; Glutamic Acid; Humans; Indoles; Male; Melanoma; Middle Aged; Molecular Targeted Therapy; Panniculitis; Point Mutation; Proto-Oncogene Proteins B-raf; Skin Neoplasms; Sulfonamides; Valine; Vemurafenib | 2013 |
Absent response of intracranial melanoma metastases harboring BRAF V600E sequence variation to vemurafenib.
Topics: Aged; Antineoplastic Agents; Brain Neoplasms; Fatal Outcome; Glutamic Acid; Humans; Ileal Neoplasms; Immunohistochemistry; Indoles; Magnetic Resonance Imaging; Male; Melanoma; Proto-Oncogene Proteins B-raf; Skin Neoplasms; Sulfonamides; Treatment Failure; Valine; Vemurafenib | 2013 |
BRAF V600E mutation in two distinct meningeal melanocytomas associated with a nevus of Ota.
Topics: Adolescent; Cell Transformation, Neoplastic; Glutamic Acid; Humans; Male; Melanocytes; Melanoma; Meningeal Neoplasms; Mutation; Nevus of Ota; Proto-Oncogene Proteins B-raf; Signal Transduction; Skin Neoplasms; Valine | 2014 |
BRAF inhibition for advanced locoregional BRAF V600E mutant melanoma: a potential neoadjuvant strategy.
Topics: Amino Acid Substitution; Antineoplastic Combined Chemotherapy Protocols; Disease Progression; Female; Follow-Up Studies; Glutamic Acid; Humans; Imidazoles; Indoles; Male; Melanoma; Middle Aged; Molecular Targeted Therapy; Mutation, Missense; Neoadjuvant Therapy; Oximes; Protein Kinase Inhibitors; Proto-Oncogene Proteins B-raf; Pyridones; Pyrimidinones; Retrospective Studies; Skin Neoplasms; Sulfonamides; Treatment Outcome; Valine; Vemurafenib | 2016 |
Antitumor Activity of BRAF Inhibitor and IFNα Combination in BRAF-Mutant Melanoma.
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Cell Line, Tumor; Cell Proliferation; Down-Regulation; Female; Flow Cytometry; Gene Expression Regulation, Neoplastic; Glutamic Acid; Humans; Immunohistochemistry; Interferon-alpha; MAP Kinase Signaling System; Melanoma; Mice; Mice, Inbred NOD; Mice, SCID; Mutation; Proto-Oncogene Proteins B-raf; Receptor, Interferon alpha-beta; Signal Transduction; Skin Neoplasms; Valine | 2016 |
Extensive oral shedding of human herpesvirus 8 in a renal allograft recipient.
Topics: Acyclovir; Adult; Antiviral Agents; Blood; Colonic Neoplasms; DNA, Viral; Genetic Variation; Herpesvirus 8, Human; Humans; Immunophenotyping; Immunosuppression Therapy; Kidney Transplantation; Leukocytes; Male; Molecular Sequence Data; Mouth Mucosa; Saliva; Sarcoma, Kaposi; Skin Neoplasms; Stomach Neoplasms; Valacyclovir; Valine; Viral Load; Virus Shedding | 2009 |
An inexpensive, specific and highly sensitive protocol to detect the BrafV600E mutation in melanoma tumor biopsies and blood.
Topics: Amino Acid Substitution; Biopsy; Blood Chemical Analysis; Cell Line, Tumor; Cost-Benefit Analysis; Cytogenetic Analysis; DNA Mutational Analysis; Glutamic Acid; HT29 Cells; Humans; Melanoma; Models, Biological; Proto-Oncogene Proteins B-raf; Reverse Transcriptase Polymerase Chain Reaction; Sensitivity and Specificity; Skin Neoplasms; Valine | 2010 |
Stability of BRAF V600E mutation in metastatic melanoma: new insights for therapeutic success?
Topics: Amino Acid Substitution; Disease Progression; Glutamic Acid; Humans; Melanoma; Mutation, Missense; Neoplasm Metastasis; Prognosis; Proto-Oncogene Proteins B-raf; Selection, Genetic; Skin Neoplasms; Treatment Outcome; Valine | 2011 |
Prevalence of BRAF V600E mutation in Chinese melanoma patients: large scale analysis of BRAF and NRAS mutations in a 432-case cohort.
Topics: Adult; Aged; Amino Acid Substitution; Asian People; Cohort Studies; DNA Mutational Analysis; Female; Genes, ras; Glutamic Acid; Humans; Male; Melanoma; Middle Aged; Mutation Rate; Mutation, Missense; Prognosis; Proto-Oncogene Proteins B-raf; Skin Neoplasms; Valine | 2012 |
Disseminated infections due to Immune Reconstitution Inflammatory Syndrome after highly active antiretroviral therapy--report of 3 cases from Nigeria.
Topics: Acyclovir; Adult; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Antiviral Agents; CD4 Lymphocyte Count; Disease Susceptibility; Fatal Outcome; Female; Herpes Zoster; HIV Infections; HIV-1; Humans; Immune Reconstitution Inflammatory Syndrome; Nigeria; Respiratory Tract Neoplasms; Sarcoma, Kaposi; Skin Neoplasms; Tuberculosis, Miliary; Valacyclovir; Valine; Viral Load; Viremia; Young Adult | 2011 |
Abrogation of BRAFV600E-induced senescence by PI3K pathway activation contributes to melanomagenesis.
Topics: Amino Acid Substitution; Cell Proliferation; Cellular Senescence; Cyclin-Dependent Kinase Inhibitor p15; Enzyme Activation; Fibroblasts; Glutamic Acid; Humans; Melanocytes; Melanoma; Nevus; Phosphatidylinositol 3-Kinases; Proto-Oncogene Proteins B-raf; Proto-Oncogene Proteins c-akt; PTEN Phosphohydrolase; Skin Neoplasms; Valine | 2012 |
BRAF inhibitor activity in V600R metastatic melanoma.
Topics: Administration, Oral; Adolescent; Adult; Aged; Aged, 80 and over; Amino Acid Substitution; Antineoplastic Agents; Arginine; Compassionate Use Trials; Female; Humans; Imidazoles; Male; Melanoma; Middle Aged; Mutation, Missense; Neoplasm Metastasis; Oximes; Protein Kinase Inhibitors; Proto-Oncogene Proteins B-raf; Skin Neoplasms; Valine; Young Adult | 2013 |
A novel methionine-53-valine mutation of p16 in a hereditary melanoma kindred.
Topics: Adult; Cyclin-Dependent Kinase Inhibitor p16; Female; Germ-Line Mutation; Humans; Male; Melanoma; Methionine; Pedigree; Point Mutation; Skin Neoplasms; Valine | 2004 |
Detection of the BRAF V600E mutation in melanocytic lesions using the ligase detection reaction.
Topics: Base Sequence; DNA; DNA Mutational Analysis; Dysplastic Nevus Syndrome; Glutamic Acid; Humans; Ligases; Melanocytes; Melanoma; Molecular Sequence Data; Mutation; Nevus; Proto-Oncogene Proteins B-raf; Sensitivity and Specificity; Skin Neoplasms; Valine | 2005 |
Distinct clinical and pathological features are associated with the BRAF(T1799A(V600E)) mutation in primary melanoma.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Alanine; Child; Female; Gene Frequency; Glutamic Acid; Humans; Male; Melanoma; Middle Aged; Multivariate Analysis; Mutation; Pigmentation; Proto-Oncogene Proteins B-raf; Skin Neoplasms; Threonine; Valine | 2007 |
Structural and mutational analysis of the xeroderma pigmentosum group D (XPD) gene.
Topics: Alleles; Amino Acid Sequence; Animals; Base Sequence; Cell Line; Cell Survival; Cloning, Molecular; DNA; DNA Helicases; DNA Mutational Analysis; DNA Primers; DNA Repair; DNA-Binding Proteins; Exons; Fishes; Genes, Recessive; Humans; Leucine; Mice; Molecular Sequence Data; Plasmids; Point Mutation; Polymerase Chain Reaction; Proteins; Saccharomyces cerevisiae; Schizosaccharomyces; Sequence Homology, Amino Acid; Skin Neoplasms; Transcription Factors; Ultraviolet Rays; Valine; Xeroderma Pigmentosum; Xeroderma Pigmentosum Group D Protein | 1994 |
Further evidence for ultraviolet light induction of CDKN2 (p16INK4) mutations in sporadic melanoma in vivo.
Topics: Alanine; Alleles; Arginine; Carrier Proteins; Cyclin-Dependent Kinase Inhibitor p16; DNA, Neoplasm; Enzyme Inhibitors; Exons; Heterozygote; Humans; Leucine; Melanoma; Mutation; Polymerase Chain Reaction; Skin; Skin Neoplasms; Ultraviolet Rays; Valine | 1997 |
Genotype-phenotype relationships in U.S. melanoma-prone families with CDKN2A and CDK4 mutations.
Topics: Adolescent; Adult; Age Factors; Aged; Arginine; Aspartic Acid; Cyclin-Dependent Kinases; Cysteine; Genes, p16; Genotype; Germ-Line Mutation; Glycine; Haplotypes; Humans; Melanoma; Middle Aged; Nevus; Pancreatic Neoplasms; Phenotype; Skin Neoplasms; Statistics, Nonparametric; Tryptophan; United States; Valine | 2000 |